Article Versions Notes

Raineri F, Bourgoin-Voillard S, Cossutta M, Habert D, Ponzo M, Houppe C, Vallée B, Boniotto M, Chalabi-Dchar M, Bouvet P, et al. Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma. Cancers. 2021; 13(12):2986. https://doi.org/10.3390/cancers13122986

Raineri, Fabio, Sandrine Bourgoin-Voillard, Mélissande Cossutta, Damien Habert, Matteo Ponzo, Claire Houppe, Benoît Vallée, Michele Boniotto, Mounira Chalabi-Dchar, Philippe Bouvet, and et al. 2021. "Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma" Cancers 13, no. 12: 2986. https://doi.org/10.3390/cancers13122986

Raineri, F., Bourgoin-Voillard, S., Cossutta, M., Habert, D., Ponzo, M., Houppe, C., Vallée, B., Boniotto, M., Chalabi-Dchar, M., Bouvet, P., Couvelard, A., Cros, J., Debesset, A., Cohen, J. L., Courty, J., & Cascone, I. (2021). Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma. Cancers, 13(12), 2986. https://doi.org/10.3390/cancers13122986